Long-term haloperidol administration enhances and short-term administration attenuates the behavioral effects of cocaine in a place conditioning procedure

Psychopharmacology

Volumn 128, Issue 3, 1996, Pages 304-312

  Kosten, Therese A ^a   DeCaprio, Jenine L ^a   Nestler, Eric J ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Chronic treatment; Cocaine; Context conditioning; Dopamine antagonist; Haloperidol; Neuroleptics; Rats; Substance abuse

Indexed keywords

COCAINE; DOPAMINE RECEPTOR BLOCKING AGENT; HALOPERIDOL;

ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR; CONDITIONING; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG ANTAGONISM; DRUG BLOOD LEVEL; DRUG POTENTIATION; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MESOLIMBIC DOPAMINERGIC SYSTEM; NONHUMAN; PLACE PREFERENCE; PRIORITY JOURNAL; RAT; SCHIZOPHRENIA; SUBSTANCE ABUSE;

ANALYSIS OF VARIANCE; ANIMALS; BEHAVIOR, ANIMAL; BODY WEIGHT; COCAINE; CONDITIONING, OPERANT; DISCRIMINATION (PSYCHOLOGY); DOGS; DOPAMINE ANTAGONISTS; DOPAMINE UPTAKE INHIBITORS; HALOPERIDOL; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0029808165     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002130050138     Document Type: Article

References (52)

1. Barret RL, Appel JB (1989) Effects of stimulation and blockade of dopamine receptor subtypes on the discriminative stimulus properties of cocaine. Psychopharmacology 99: 13-16
2. Beninger RJ, Herz RS (1986) Pimozide blocks establishment but not expression of cocaine-produced environment-specific conditioning. Life Sci 38: 1425-1431
3. 1 antagonists: comparison with other drugs and modification by haloperidol. J Pharmacol Exp Ther 245: 471-478
4. Brady K, Anton R, Ballenger JC, Lydiard RB, Adinoff B, Selander J (1990) Cocaine abuse among schizophrenic patients. Am J Psychiatry 147: 1164-1167
5. Burt DR, Creese I, Snyder SH (1977) Antischizophrenic drugs: chronic treatment elevates dopamine receptor binding in brain. Science 196: 326-328
6. Calcagnetti DJ, Schechter MD (1993) Extinction of cocaine-induced place approach in rats: a validation of the "biased" conditioning procedure. Brain Res Bull 30: 695-700
7. 2 receptor function in rats. J Pharmacol Exp Ther 266: 585-592
8. Carr GD, Fibiger HC, Phillips AG (1989) Conditioned place preference as a measure of drug reward. In: Liebman JM, Cooper SJ (eds) The neuropharmacological basis of reward. Oxford University Press, New York, pp 264-319
9. Chiodo LA, Bunney BS (1983) Typical and atypical neuroleptics: differential effects of chronic administration on the activity of A9 and A10 midbrain dopaminergic neurons. J Neurosci 3: 1607-1619
10. 2 dopamine receptor classification and its functional implications. Synapse 1: 347-388
11. Colpaert FC, Niemegeers CJE, Janssen PA (1978) Neuroleptic interference with the cocaine cue: internal stimulus control of behavior and psychosis. Psychopharmacology 58: 247-255
12. Cuffel BJ (1992) Prevalence estimates of substance abuse in schizophrenia and their correlates. J Nerv Ment Dis 180: 589-592
13. Dixon L, Hass G, Weiden P, Sweeney J, Francis A (1991) Drug abuse in schizophrenic patients: clinical correlates and reasons for use. Am J Psychiatry 148: 224-230
14. Emmett-Oglesby M, Mathis D (1989) Chronic administration of SCH23390 produces sensitization to the discriminative stimulus properties of cocaine. In: Harris LS (ed) Problems of drug dependence 1988. US Government Printing Office, Washington, DC, p 367
15. Fitzgerald LW, Deutch AY, Gasic G, Heinemann SF, Nestler EJ (1995) Regulation of cortical and subcortical glutamate receptor subunit expressio by antipsychotic drugs. J Neurosci 15: 2453-2461
16. Gui-Hua C, Perry BD, Woolverton WL (1992) Effects of chronic SCH 23390 or acute EEDQ on the discriminative stimulus effects of SKF 38393. Pharmacol Biochem Behav 41: 321-327
17. 3H]-catecholamines by homogenates of rat corpus striatum and cerebral cortex: effects of amphetamine analogues. Neuropharmacology 12: 659-679
18. 2-selective dopamine antagonists in the squirrel monkey. J Pharmacol Exp Ther 262: 901-915
19. Jatlow P, Nadim H (1990) Determination of cocaine concentrations in plasma by high-performance liquid chromatography. Clin Chem 36: 1436-1439
20. Jatlow P, Miller R, Swigar M (1982) Measurement of haloperidol in human plasma using reversed-phase high-performance liquid chromatography. J Chromatogr 227: 223-238
21. Kleven MS, Woolverton WL (1990) Effects of continuous infusions of SCH 23390 on cocaine- or food-maintained behavior in rhesus monkeys. Behav Pharmacol 1: 365-373
22. Kleven MS, Anthony EW, Woolverton WL (1990) Pharmacological characterization of the discriminative stimulus effects of cocaine in rhesus monkeys. J Pharmacol Exp Ther 254: 312-317
23. Koob GF, Bloom FE (1988) Cellular and molecular mechanisms of drug dependence. Science 242: 715-723
24. Kosten TA, Marby DW, Nestler EJ (1991) Cocaine conditioned place preference is attenuated by chronic buprenorphine. Life Sci 49: PL201-PL206
25. Kosten TA, Miserendino MJD, Marby DW, Nestler EJ (1994) Chronic haloperidol enhances cocaine conditioned place preference. In: Harris LS (ed) Problems of drug dependence 1993: proceedings of the 55th Annual Scientific Meeting, College on the Problems of Drug Dependence. US Dept. of Health and Human Services, National Institute on Drug Abuse. Research Monograph #141; vol. II, p 13
26. 2 receptor proliferation induced by dopamine denervation and chronic selective antagonist administration: evidence from quantitative autoradiography indicates a single mechanism of action. Brain Res 502: 223-232
27. 2 synergism are unrelated to changes in striatal receptor density. Synapse 12: 14-26
28. LeDuc PA, Mittleman G (1993) Interactions between chronic haloperidol treatment and cocaine in rats: an animal model of intermittent cocaine use in neuroleptic treated populations. Psychopharmacology 110: 427-436
29. LeDuc PA, Mittleman G (1995) Schizophrenia and psychostimulant abuse: a review and re-analysis of clinical evidence. Psychopharmacology 121: 407-427
30. Martin-Iverson MT, Reimer AR (1994) Effects of nimodipine and/or haloperidol on the expression of conditioned locomotion and sensitization to cocaine in rats. Psychopharmacology 114: 315-320
31. Meyer RE (1992) New pharmacotherapies for cocaine dependence... revisited. Arch Gen Psychiat 49: 900-904
32. Muller P, Seeman P (1978) Dopaminergic supersensitivity after neuroleptics: time-course and specificity. Psychopharmacology 60: 1-11
33. Nobiletti JB, Jatlow P, Bradherry CW (1994) Differences in bioavailability between cocaine and cocaethylene and their implications for drug-reward studies. Psychopharmacology 116: 273-278
34. Pettit HO, Justice JB Jr (1989) Dopamine in the nucleus accumbens during cocaine self-administration as studied by in vivo microdialysis. Pharmacol Biochem Behav 34: 899-904
35. Rebec GV, Peirson EE, McPherson FA, Brugge K (1982) Differential sensitivity to amphetamine following long-term treatment with clozapine or haloperidol. Psychopharmacology 77: 360-366
36. Reid LD, Marglin SH, Mattie ME, Hubbell CL (1989) Measuring morphine's capacity to establish a place preference. Pharmacol Biochem Behav 33: 346-350
37. Ritz MC, Lamb RJ, Goldberg SR, Kuhar MJ (1987) Cocaine receptors on dopamine transporters are related to self-administration of cocaine. Science 237: 1219-1223
38. Roberts DCS, Vickers G (1984) Atypical neuroleptics increase self-administration of cocaine: an evaluation of a behavioural screen for antipsychotic activity. Psychopharmacology 82: 135-139
39. Roberts DCS, Loh EA, Vickers G (1989) Self-administration of cocaine on a progressive ratio schedule in rats: dose-response relationship and effect of haloperidol pretreatment. Psychopharmacology 97: 535-538
40. See RE, Ellison GD (1990) Comparison of chronic administration of haloperidol and the atypical neuroleptics, clozapine and raclopride, in an animal model of tardive dyskinesia. Eur J Pharmacol 282: 175-186
41. A and dopamine D-2, but not dopamine D-1 receptors. Life Sci 44: 229-236
42. Seeger TF, Thal L, Gardner EL (1982) Behavioral and biochemical aspects of neuroleptic-induced dopaminergic supersensitivity: studies with chronic clozapine and haloperidol. Psychopharmacology 76: 182-187
43. Shippenberg TS, Herz A (1988) Motivational effects of opioids: influence of D-1 versus D-2 receptor antagonists. Eur J Pharmacol 151: 233-242
44. 2 dopamine receptors in the behavioral effects of cocaine. Neurochem Int 20: 147B-152S
45. Spyraki C, Fibiger HC, Phillips AG (1982) Cocaine-induced place preference conditioning: lack of effects of neuroleptics and 6-hydroxydopamine lesions. Brain Res 253: 195-203
46. Stinus L, Nadaud D, Deminiere JM, Jauregui J (1989) Chronic flupentixol treatment potentiates the reinforcing properties of systemic heroin administration. Biol Psychiatry 26: 363-371
47. Tarsy D, Baldessarini RJ (1974) Behavioural supersensitivity to apomorphine following chronic treatment with drugs which interfere with the synaptic function of catecholamines. Neuropharmacology 13: 927-940
48. Weiss SRB, Post RM, Pert A, Woodward R, Murmun D (1989) Context-dependent cocaine sensitization: differential effect of haloperidol on development versus expression. Pharmacol Biochem Behav 24: 655-661
49. White FJ, Wang RY (1983) Comparison of the effects of chronic haloperidol treatment on A9 and A10 dopamine neurons in the rat. Life Sci 32: 983-993
50. Wise RA, Rompre PP (1989) Brain dopamine and reward. In: Rosenzweig MR, Porter LL (eds) Annual review of psychology. Annual Reviews, Palo Alto, pp 191-226
51. Witkin JM, Nichols DE, Terry P, Katz JL (1991) Behavioral effects of selective dopaminergic compounds in rats discriminating cocaine injections. J Pharmacol Exp Ther 257: 706-713
52. Woolverton WL, Johnson KM (1991) Neurobiology of cocaine abuse. Trends Pharmacol Sci 13: 193-201